22 October 2024
22 October 2024
A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of Sanofi鈥檚 consumer health business.
The funding will support Seaport鈥檚 technology platform, which helps drugs be absorbed more efficiently through the lymphatic system.
A partial clinical hold was placed on the registrational trial after results showed variance between squamous and non-squamous NSCLC patient responses.
MCO-010 has garnered significant interest as a gene-agnostic optogenetic therapy, with the potential to address all RP genetic variations.
As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier鈥檚 Voranigo.
The collaboration will target respiratory and kidney diseases, aiming to improve patient outcomes.
ZORYVE is the first topical medication with a new mechanism of action for the condition to be approved in Canada.
Charles River will act as the contract development and manufacturing organisation for FibroBiologics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
